Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies and for the preparation of autologous platelet-rich plasma (PRP) from the patient’s own blood, to be used in bedside procedures.
Regen Lab SA manufactures several CE-marked products to fit to medical disciplines where PRP represents a treatment option. Patients can expect very good outcomes for the treatment of their chronic and surgical wounds, dry eye syndrome and other ophthalmic conditions, sport-related wounds and even alopecia, as demonstrated through the clinical studies Regen Lab has set-up over the past few years.
In the last five years, over 2 million patients have been treated using Regen Lab products and another 10 thousand have benefited from bone marrow stem cell kits. The company invested in a new Good Manufacturing Practice (GMP) facility located at the Mont-sur-Lausanne (canton of Vaud) beginning production in 2017. It is planned that this new peak performance industrial platform will allow the treatment of over 1 million patients per year.